Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Dexmedetomidine
(D01205)		1件: Dexmedetomidine2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride (D01205) 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬15件: 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
2Dexmedetomidine 1
(D01205)		1件: Dexmedetomidine2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride (D01205) 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 280 💬
3Dexmedetomidine 2
(D01205)		1件: Dexmedetomidine2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride (D01205) 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 280 💬
4Dexmedetomidine 3
(D01205)		1件: Dexmedetomidine2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride (D01205) 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 280 💬
5Dexmedetomidine group
(D01205)		1件: Dexmedetomidine2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride (D01205) 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 70 💬
6Dexmedetomidine HCL 100 MCG/ML INJ
(D01205)		1件: Dexmedetomidine2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride (D01205) 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 215 💬
7Dexmedetomidine hydrochloride
(D01205)		1件: Dexmedetomidine2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride (D01205) 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 70 💬
8Dexmedetomidine hydrochloride infusion
(D01205)		1件: Dexmedetomidine2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride (D01205) 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 6 💬
9Dexmedetomidine injection
(D01205)		1件: Dexmedetomidine2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride (D01205) 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 70 💬
10Dexmedetomidine with ropivacaine
(D01205)		2件: Dexmedetomidine,
Ropivacaine		4件: Dexmedetomidine ,
Dexmedetomidine hydrochloride (D01205),
Ropivacaine hydrochloride ,
Ropivacaine 💬 		8件: ADRA2A,
ADRA2B,
ADRA2C,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		7件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway 💬1件: 70 💬
11Fentanyl (LOW dose) + dexmedetomidine
(D01205)		1件: Fentanyl3件: Fentanyl ,
Fentanyl citrate ,
Fentanyl hydrochloride 💬 		1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 215 💬
12Scopolamine, atropine, edaravone and dexmedetomidine
(D01205)		2件: Edaravone,
Scopolamine		2件: Scopolamine ,
Edaravone 💬 		5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬1件: 2 💬